Yes, genetic variations can significantly impact ADME processes. Polymorphisms in metabolic enzymes like cytochrome P450 can alter drug metabolism, leading to increased susceptibility to toxicity. Personalized medicine approaches aim to tailor treatments based on individual genetic profiles to minimize adverse effects.
